Latest Morning Briefing Stories
The Biden administration has started to speed efforts to reverse health policies forged under Donald Trump. Most recently, the administration overturned a ban on fetal tissue research and canceled a last-minute extension of a Medicaid waiver for Texas. That latter move may delay the Senate confirmation of President Joe Biden’s nominee to head the Medicare and Medicaid programs, as Sen. John Cornyn (R-Texas) seeks to fight back. Anna Edney of Bloomberg News, Rachel Cohrs of Stat and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Public health resources have shifted from one pandemic to the other, and experts fear steep declines in testing and diagnoses mean more people will contract HIV and die of AIDS.
At least 5,800 people have fallen ill or tested positive for covid two weeks or more after being fully vaccinated, according to the CDC. “I now tell everyone, including my colleagues, not to let their guard down.”
Podcast panelists discuss a range of health policy developments, from the latest in the covid vaccination effort to the HHS budget, among other things.
A misguided federal program called the Unapproved Drugs Initiative, which put the FDA’s stamp of approval on old drugs, led to higher prices. It’s scrapped. So now what?
Expertos en salud se preguntan si el freno a la vacuna de J&J a causa de seis casos de mujeres que desarrollaron coágulos luego de recibirla puede impactar negativamente en los esfuerzos de inmunización.
The messaging surrounding vaccine safety and efficacy may mean as much as the science.
Over-the-counter covid tests could help speed the economy’s recovery, allowing students and workers to test themselves at home and get quick results. Could they become as ubiquitous as toothpaste and cold remedies on store shelves, or will demand dry up as the nation gets vaccinated?
The ink is barely dry on the recent covid relief bill, but Democrats in Congress and President Joe Biden are wasting no time gearing up for their next big legislative package. Meanwhile, predictions of more states expanding Medicaid have proved premature. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Kimberly Leonard of Business Insider join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Lauren Weber, who reported the latest KHN-NPR “Bill of the Month” episode.
A nationwide poll released by KFF also revealed which arguments are most compelling to persuade people to get a shot — and which ones are unlikely to work.
Experts say there’s nothing new about the research underpinning the covid vaccines and that they were tested in more participants than many other approved vaccines.
Hay medicamentos aprobados hace años que podrían investigarse en profundidad para tratar covid. Pero no hay interés porque no generarían grandes ganancias.
Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions.
In his campaign, President Joe Biden promised to undo policies, particularly health policies, implemented by former President Donald Trump. Yet, despite immense executive power, reversing four years of action takes time and resources.
After a bruising confirmation process, Xavier Becerra was sworn in as secretary of Health and Human Services this week. The Senate also confirmed the nominations of former U.S. Surgeon General Vivek Murthy to return to the post he held in the Obama administration, and former Pennsylvania health secretary Rachel Levine as assistant secretary for health. Levine is the first openly transgender person to receive Senate confirmation. Meanwhile, questions continue to swirl around the AstraZeneca covid vaccine, which some public health experts worry will create more hesitancy toward other vaccines.
Progressive and conservative Democratic lawmakers, as well as President Joe Biden, are in favor of authorizing federal officials to negotiate with drugmakers over what Medicare pays for at least some of the most expensive brand-name drugs and to base those prices on the drugs’ clinical benefits. Such a measure could put Republicans in the uncomfortable position of opposing an idea that most voters from both parties generally support.
Expertos felicitan las acciones de la administración Biden con las vacunas de covid, pero creen que en los próximos meses debería haber un enfoque global para que el mundo esté innmunizado.
For now, there’s not enough vaccine for the U.S., but that could change within a few months. Vaccinating other nations will be key to stopping the pandemic – and keeping it away from our shores.
The covid relief bill signed by President Joe Biden includes a long list of new health benefits for consumers. But many eligible people may have difficulty taking advantage of them because of the interaction with the income tax system and a lack of expert guidance. Meanwhile, Democrats are debating internally about what should come next on the health agenda. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more.
El área de Long Beach, que tiene su propio departamento de salud, abrió un mega sitio de vacunación contra covid enfocado en un grupo vulnerable: los trabajadores de la industria de alimentación.